Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 6d
Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun
Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 4d Vanrafia The Lancet Pharma
ASCO 2026: Mixed Sclc result for Legend’s LB2102, Novartis expedites manufacture Pharmaceutical Technology 7d Biotech Biotechnology Pharma All sources
Novartis Cosentyx shows sustained remission in polymyalgia rheumatica RTT News 5d Cosentyx Biotech Pharma
